{"id":"W2345027487","doi":"10.1038/bjc.2016.72","title":"Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Refractory (planetary science); Prodrug; Medicine; Internal medicine; Oncology; Clinical trial; Phases of clinical research; Cancer research; Pharmacology; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00119115,0.001343576,0.001253532,0.0002433403,0.000248896,0.0006934904,0.0005629939,0.0009062038,0.001380579],"category_scores_gemma":[0.0005388843,0.0002937986,0.0009236984,0.0002647513,0.0005857356,0.0005440296,0.0002721458,0.002175316,0.000431546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007345984,"about_ca_system_score_gemma":0.0007744801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006676682,"about_ca_topic_score_gemma":0.001181178,"domain_scores_codex":[0.9997665,0.00009629405,0.00001380607,0.00003392773,0.00002350655,0.00006594008],"domain_scores_gemma":[0.9995815,0.00007047778,0.00008331465,0.00003415941,0.00003378756,0.0001967527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3635615,0.07047037,0.01154161,0.001997618,0.002561497,0.001391247,0.001222405,0.0112106,0.2719986,0.000508048,0.007576788,0.2559598],"study_design_scores_gemma":[0.2302565,0.6885946,0.02938543,0.00008685594,0.001166797,0.001855591,0.0001321453,0.002796476,0.03764956,0.0002814943,0.007733126,0.00006148093],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926397,0.003598982,0.0007431949,0.0002789406,0.00004410494,0.000835191,0.0006003539,0.00009750707,0.001162015],"genre_scores_gemma":[0.9891682,0.003475378,0.001766295,0.0005203427,0.00009254663,0.000749623,0.002552481,0.00004096983,0.001634197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001380579,"threshold_uncertainty_score":0.006299496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.024082570526279,"score_gpt":0.3349164922363005,"score_spread":0.3108339217100216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}